Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03850990 · ClinicalTrials.gov registry record · NA
Effect of Gut-Cued Eating on BMI and Efficacy of Open-Label Placebo to Augment Weight Loss
A NA study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 31
- Enrollment target
NCT03850990 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 31 participants.
The verdict
NCT03850990, a NA study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
Study Summary
The study will assess the effect of attending to stomach-cues of hunger and fullness on body weight and any additional benefit provided by open-label placebo.
Interventions
- BEHAVIORAL Placebo pill and no placebo pill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2019-09-25 |
| Est. Completion | 2020-05-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03850990
The ClinicalTrials.gov registry entry for NCT03850990 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Placebo pill and no placebo pill is the first listed.
NCT03850990 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03850990 about?
NCT03850990 is a clinical study titled "Effect of Gut-Cued Eating on BMI and Efficacy of Open-Label Placebo to Augment Weight Loss". The study will assess the effect of attending to stomach-cues of hunger and fullness on body weight and any additional benefit provided by open-label placebo.
What is the current status of trial NCT03850990?
This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2019-09-25. Estimated completion is 2020-05-30.
What interventions are being tested in trial NCT03850990?
The interventions under investigation include: Placebo pill and no placebo pill (BEHAVIORAL).
Who is sponsoring clinical trial NCT03850990?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.